>中东和非洲泻药市场，按类型（渗透性泻药、刺激性泻药、容积性泻药、润滑剂和润肤剂泻药）、口味（有味和无味）、来源（天然、合成和其他）、适应症（慢性便秘、便秘性肠易激综合征、阿片类药物引起的便秘、急性便秘和其他）、购买方式（处方和非处方）、剂型（片剂、胶囊、粉末、液体和凝胶、栓剂和其他）、给药途径（口服和直肠）、人群类型（儿童和成人）、销售渠道（医院、老年护理中心、家庭医疗保健、药店、杂货店/健康和美容店和其他）、分销渠道（直销、批发商和其他）、国家（南非、沙特阿拉伯、阿联酋、埃及、科威特、以色列和中东及非洲其他地区）行业趋势和预测至 2028 年。
市场分析和洞察：中东和非洲泻药市场
预计中东和非洲泻药市场将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析，在 2021 年至 2028 年的预测期内，该市场将以 4.9% 的复合年增长率增长，预计到 2028 年将达到 3.9624 亿美元。泻药产品的高水平安全性以及对使用天然、合成和可生物降解材料生产泻药的日益重视是预测期内推动市场需求的主要驱动力。
泻药是增加/刺激排便或软化粪便的药剂。它们有助于加速肠道运输，从而加快消化道的运动以刺激排便。它用于治疗便秘，这是一种以排便困难、不频繁和有时疼痛为特征的疾病。泻药可在柜台 (OTC)购买。泻药主要有四种类型：渗透性泻药、刺激性泻药、容积性泻药、润滑剂和润肤性泻药。
泻药具有以下特点：对安全有效产品的需求不断增长，这将影响制造商向市场推出新产品，从而增加其需求；增加研发投资也会导致市场增长。目前正在进行各种研究，预计这将为制造商创造竞争优势，以开发新的创新产品，从而为泻药市场提供各种其他机会。然而，替代产品的可用性和泻药对阿片类药物引起的便秘的疗效较低，这些因素预计将在预测期内抑制市场增长。
Laxative market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.
Middle East and Africa laxative Market Scope and Market Size
Middle East and Africa laxative market is categorized into ten notable segments based on the type, flavors, source, indication, mode of purchase, dosage form, route of administration, population type, sales channel and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of type, the Middle East and Africa laxative market is segmented into osmotic laxative, bulk laxative, stimulant laxative and lubricant and emolloient laxative. In 2021, stimulant laxatives segment is dominating the market because these laxatives function are used to clean out the intestines before a bowel examination/surgery.
- On the basis of flavors, the Middle East and Africa laxative market is segmented into with flavor and without flavor. In 2021, with flavor segment is dominating the market because of its market acceptance and popularity among the consumers.
- On the basis of source, the Middle East and Africa laxative market is segmented into natural, synthetic and others. In 2021, synthetic segment is dominating the market due to increased availability of synthetic laxatives as over-the-counter medications.
- On the basis of indication, the Middle East and Africa laxative market is segmented into chronic constipation, irritable bowel syndrome with constipation, opioid-induced constipation, acute constipation and others. In 2021, chronic constipation segment is dominating the market because easily availability of OTC drugs for constipation.
- On the basis of mode of purchase, the Middle East and Africa laxative market is segmented into prescription and over the counter. In 2021, over-the-counter segment is dominating the market because of lower costs and it allows customization of the medicine as per patients' need.
- On the basis of dosage form, the Middle East and Africa laxative market is segmented into tablets, capsules, powder, liquids & gels, suppositories and others. In 2021, tablets segment is dominating the market as it is the most economical method of drug administration.
- 根据给药途径，中东和非洲泻药市场分为口服和直肠给药。2021 年，口服药物占据市场主导地位，因为它是最安全、最方便、最经济的给药方式。
- 根据人口类型，中东和非洲泻药市场分为儿童和成人。2021 年，由于日常生活的变化，例如旅行、吃饭或睡觉时间不同，成人群体预计将在中东和非洲泻药市场占据主导地位。
- 根据销售渠道，中东和非洲泻药市场分为医院、老年护理中心、家庭医疗保健、药店、杂货店/保健和美容店等。 2021 年，医院部门预计将主导中东和非洲泻药市场，因为医院是一家拥有组织良好的医务和专业人员的医疗机构。它为患者提供医疗、护理和其他健康相关服务。
- 根据分销渠道，中东和非洲泻药市场分为直销、批发和其他。 2021 年，直销市场预计将主导中东和非洲泻药市场，因为它可以直接与卖家联系，并可以直接向客户销售产品。
泻药市场国家层面分析
对泻药市场进行分析，并根据类型、口味、来源、适应症、购买方式、剂型、给药途径、人群类型、销售渠道和分销渠道提供市场规模信息。
泻药市场报告涉及的国家包括沙特阿拉伯、南非、阿联酋、以色列、科威特、埃及以及中东和非洲的其他国家。
在中东和非洲地区，预计南非和科威特在 2021 年至 2028 年的预测期内将以最高的增长率增长，因为该地区老年人口的增加和高饮料消费导致便秘问题。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了中东和非洲品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少竞争而面临的挑战、销售渠道的影响。
老年人口的增长推动了中东和非洲地区泻药市场的增长
泻药市场还为您提供每个国家泻药产品行业增长的详细市场分析，包括泻药销售、泻药技术进步的影响以及监管环境的变化及其对泻药市场的支持。数据涵盖 2010 年至 2019 年的历史时期。
竞争格局和泻药市场份额分析
泻药市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对泻药市场的关注有关。
在中东和非洲泻药市场经营的主要公司包括勃林格殷格翰国际有限公司、葛兰素史克公司、拜耳公司、费森尤斯卡比奥地利有限公司、宝洁公司、太阳制药工业有限公司、赛诺菲安万特美国有限责任公司（赛诺菲的子公司）、Mallinckrodt、雅培公司、Hikma Pharmaceuticals PLC、Dr Reddy's Laboratories Ltd、Cipla Inc.、Albert David Ltd、Aspen Pharmacare Australia Pty Ltd 和 RECORDATI SpA 等。DBMR 分析师了解竞争优势，并为每个竞争对手分别提供竞争分析。
全球范围内的许多产品发布和协议也由公司发起，这也加速了泻药市场的发展。
例如，
- 2018 年 1 月，拜耳公司推出了广受欢迎的便秘药物 MiraLAX。MiraLAX 已获得 FDA 的缓刑。FDA 表示，该药物将被起诉 6 个月。拜耳公司已停止分销这种泻药，因为它会引起行为问题等副作用。因此，它导致净收入损失和市场负增长。
- 2021 年 10 月，雅培在印度推出了 Duphalac 泻药。草莓味的 Duphalac Bears 是一种泻药兼食品补充剂，符合 FSSAI 规定。它具有值得信赖的益生元的优势，并促进消化系统中有益细菌的生长。该产品的推出将为儿童健康改善迈出重要一步。它将带来净销售额的增加和更多的产品范围。
市场参与者的合作、产品发布、业务扩展、奖励和认可、合资企业和其他策略正在增强公司在泻药市场的市场，这也为组织改善其泻药供应提供了好处。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA LAXATIVE MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MIDDLE EAST AND AFRICA LAXATIVE MARKET: SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET INDICATION COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTERS FIVE FORCES MODEL
4.2 PESTEL ANALYSIS
5 EPIDEMIOLOGY
6 MIDDLE EAST AND AFRICA LAXATIVE MARKET: REGULATIONS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASED PREVALENCE OF CONSTIPATION
7.1.2 RISE IN CLINICAL TRIALS
7.1.3 ACCLIMATIZATION OF SEDENTARY LIFESTYLE
7.1.4 RISE IN GERIATRIC POPULATION
7.1.5 RISE IN PRODUCT APPROVALS
7.2 RESTRAINTS
7.2.1 LESS EFFICACY OF LAXATIVES FOR OPIOID-INDUCED CONSTIPATION
7.2.2 AVAILABILITY OF ALTERNATIVES
7.2.3 LAXATIVE ABUSE
7.2.4 SIDE EFFECTS RELATED TO THE USE OF LAXATIVES
7.3 OPPORTUNITIES
7.3.1 RISE OF OTC LAXATIVE MEDICATIONS
7.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS
7.3.3 INCREASED USE OF BULK-LAXATIVES
7.4 CHALLENGES
7.4.1 RISE OF PRODUCT RECALL
7.4.2 PATIENT COMPLIANCE REGARDING THE USE OF LAXATIVES
8 IMPACT OF COVID-19 ON THE MIDDLE EAST AND AFRICA LAXATIVE MARKET
8.1 IMPACT ON PRICE
8.2 IMPACT ON DEMAND
8.3 IMPACT ON SUPPLY CHAIN
8.4 STRATEGIC DECISIONS FOR MANUFACTURERS
8.5 CONCLUSION
9 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY TYPE
9.1 OVERVIEW
9.2 OSMOTIC LAXATIVES
9.2.1 OSMOTIC LAXATIVES WITHOUT ELECTROLYTES
9.2.1.1 LACTULOSE
9.2.1.2 MAGNESIUM HYDROXIDE SOLUTION
9.2.1.3 EPSOM SALTS
9.2.1.4 OTHERS
9.2.2 OSMOTIC LAXATIVES WITH ELECTROLYTES
9.2.2.1 GOLYTELY
9.2.2.2 COLYTE
9.2.2.3 OTHERS
9.3 STIMULANT LAXATIVES
9.3.1 BISACODYL
9.3.2 CASTOR OIL
9.3.3 SENNA
9.3.4 PHENOLPHTALEIN
9.3.5 OTHERS
9.4 BULK LAXATIVES
9.4.1 PSYLLIUM
9.4.2 METHYL CELLULOSE
9.4.3 POLYCARBOPHIL
9.4.4 OTHERS
9.5 LUBRICANT AND EMOLLIENT LAXATIVES
9.5.1 MINERAL OIL
9.5.2 GLYCERIN SUPPOSITORIES
9.5.3 OTHERS
10 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY FLAVORS
10.1 OVERVIEW
10.2 WITH FLAVOR
10.2.1 FRUIT FLAVOR
10.2.2 HERBAL FLAVOR
10.2.3 OTHERS
10.3 WITHOUT FLAVOR
11 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY SOURCE
11.1 OVERVIEW
11.2 SYNTHETIC
11.2.1 BISACODYL
11.2.2 PICOSULPHATE
11.2.3 PHENOLPHTHALEIN
11.2.4 OXYPHENISATIN
11.3 NATURAL
11.3.1 PSYLLIUM
11.3.2 SENNA
11.3.3 RHUBARB
11.3.4 SLIPPERY ELM
12 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY INDICATION
12.1 OVERVIEW
12.2 CHRONIC CONSTIPATION
12.3 IRRITABLE BOWEL SYNDROME WITH CONSTIPATION
12.4 OPIOID-INDUCED CONSTIPATION
12.5 ACUTE CONSTIPATION
12.6 OTHERS
13 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY MODE OF PURCHASE
13.1 OVERVIEW
13.2 OVER THE COUNTER
13.3 PRESCRIPTION
14 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY DOSAGE FORM
14.1 OVERVIEW
14.2 TABLETS
14.3 CAPSULES
14.4 POWDER
14.5 LIQUID & GELS
14.6 SUPPOSITORIES
14.7 OTHERS
15 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY ROUTE OF ADMINISTRATION
15.1 OVERVIEW
15.2 ORAL
15.3 RECTAL
16 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY POPULATION TYPE
16.1 OVERVIEW
16.2 ADULTS
16.3 CHILDREN
17 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY SALES CHANNEL
17.1 OVERVIEW
17.2 HOSPITALS
17.3 PHARMACY STORES
17.4 ELDERLY CARE CENTERS
17.5 HOME HEALTHCARE
17.6 GROCERY/HEALTH AND BEAUTY STORES
17.7 OTHERS
18 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY DISTRIBUTION CHANNEL
18.1 OVERVIEW
18.2 DIRECT SALES
18.3 WHOLE SALERS
18.4 OTHERS
19 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY REGION
19.1 MIDDLE EAST & AFRICA
19.1.1 SAUDI ARABIA
19.1.2 SOUTH AFRICA
19.1.3 U.A.E.
19.1.4 ISRAEL
19.1.5 KUWAIT
19.1.6 EGYPT
19.1.7 REST OF MIDDLE EAST & AFRICA
20 MIDDLE EAST AND AFRICA LAXATIVE MARKET: COMPANY LANDSCAPE
20.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
21 SWOT ANALYSIS
22 COMPANY PROFILE
22.1 BAYER AG
22.1.1 COMPANY SNAPSHOT
22.1.2 REVENUE ANALYSIS
22.1.3 COMPANY SHARE ANALYSIS
22.1.4 PRODUCT PORTFOLIO
22.1.5 RECENT DEVELOPMENT
22.2 PROCTER & GAMBLE
22.2.1 COMPANY SNAPSHOT
22.2.2 REVENUE ANALYSIS
22.2.3 COMPANY SHARE ANALYSIS
22.2.4 PRODUCT PORTFOLIO
22.2.5 RECENT DEVELOPMENTS
22.3 FRESENIUS KABI AUSTRIA GMBH (A SUBSIDIARY OF FRESENIUS KABI AG)
22.3.1 COMPANY SNAPSHOT
22.3.2 REVENUE ANALYSIS
22.3.3 COMPANY SHARE ANALYSIS
22.3.4 PRODUCT PORTFOLIO
22.3.5 RECENT DEVELOPMENT
22.4 SANOFI-AVENTIS U.S. LLC (A SUBSIDIARY OF SANOFI)
22.4.1 COMPANY SNAPSHOT
22.4.2 REVENUE ANALYSIS
22.4.3 COMPANY SHARE ANALYSIS
22.4.4 PRODUCT PORTFOLIO
22.4.5 RECENT DEVELOPMENTS
22.5 ABBOTT
22.5.1 COMPANY SNAPSHOT
22.5.2 REVENUE ANALYSIS
22.5.3 PRODUCT PORTFOLIO
22.5.4 RECENT DEVELOPMENT
22.6 ALBERT DAVID LTD.
22.6.1 COMPANY SNAPSHOT
22.6.2 REVENUE ANALYSIS
22.6.3 PRODUCT PORTFOLIO
22.6.4 RECENT DEVELOPMENT
22.7 ASPEN PHARMACARE AUSTRALIA PTY LTD. (A SUBSIDIARY OF ASPEN HOLDINGS)
22.7.1 COMPANY SNAPSHOT
22.7.2 REVENUE ANALYSIS
22.7.3 PRODUCT PORTFOLIO
22.7.4 RECENT DEVELOPMENT
22.8 AVRIO HEALTH L.P.
22.8.1 COMPANY SNAPSHOT
22.8.2 PRODUCT PORTFOLIO
22.8.3 RECENT DEVELOPMENT
22.9 BIOCHEMIX HEALTHCARE PVT. LTD.
22.9.1 COMPANY SNAPSHOT
22.9.2 PRODUCT PORTFOLIO
22.9.3 RECENT DEVELOPMENT
22.1 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
22.10.1 COMPANY SNAPSHOT
22.10.2 REVENUE ANALYSIS
22.10.3 PRODUCT PORTFOLIO
22.10.4 RECENT DEVELOPMENT
22.11 CIPLA INC.
22.11.1 COMPANY SNAPSHOT
22.11.2 REVENUE ANALYSIS
22.11.3 PRODUCT PORTFOLIO
22.11.4 RECENT DEVELOPMENTS
22.12 DR. REDDY’S LABORATORIES LTD.
22.12.1 COMPANY SNAPSHOT
22.12.2 REVENUE ANALYSIS
22.12.3 PRODUCT PORTFOLIO
22.12.4 RECENT DEVELOPMENTS
22.13 GLAXOSMITHKLINE PLC
22.13.1 COMPANY SNAPSHOT
22.13.2 REVENUE ANALYSIS
22.13.3 PRODUCT PORTFOLIO
22.13.4 RECENT DEVELOPMENT
22.14 HERMES PHARMA
22.14.1 COMPANY SNAPSHOT
22.14.2 PRODUCT PORTFOLIO
22.14.3 RECENT DEVELOPMENTS
22.15 HIKMA PHARMACEUTICALS PLC
22.15.1 COMPANY SNAPSHOT
22.15.2 REVENUE ANALYSIS
22.15.3 PRODUCT PORTFOLIO
22.15.4 RECENT DEVELOPMENT
22.16 LNK INTERNATIONAL, INC.
22.16.1 COMPANY SNAPSHOT
22.16.2 PRODUCT PORTFOLIO
22.16.3 RECENT DEVELOPMENT
22.17 MALLINCKRODT
22.17.1 COMPANY SNAPSHOT
22.17.2 REVENUE ANALYSIS
22.17.3 PRODUCT PORTFOLIO
22.17.4 RECENT DEVELOPMENTS
22.18 PRESTIGE CONSUMER HEALTHCARE INC.
22.18.1 COMPANY SNAPSHOT
22.18.2 REVENUE ANALYSIS
22.18.3 PRODUCT PORTFOLIO
22.18.4 RECENT DEVELOPMENT
22.19 RECORDATI S.P.A.
22.19.1 COMPANY SNAPSHOT
22.19.2 REVENUE ANALYSIS
22.19.3 PRODUCT PORTFOLIO
22.19.4 RECENT DEVELOPMENT
22.2 SALIX PHARMACEUTICALS (A SUBSIDIARY OF BAUSCH HEALTH COMPANIES INC.)
22.20.1 COMPANY SNAPSHOT
22.20.2 REVENUE ANALYSIS
22.20.3 PRODUCT PORTFOLIO
22.20.4 RECENT DEVELOPMENTS
22.21 SUN PHARMACEUTICAL INDUSTRIES LTD.
22.21.1 COMPANY SNAPSHOT
22.21.2 REVENUE ANALYSIS
22.21.3 PRODUCT PORTFOLIO
22.21.4 RECENT DEVELOPMENT
22.22 TORRENT PHARMACEUTICALS LTD.
22.22.1 COMPANY SNAPSHOT
22.22.2 REVENUE ANALYSIS
22.22.3 PRODUCT PORTFOLIO
22.22.4 RECENT DEVELOPMENT
23 QUESTIONNAIRE
24 RELATED REPORTS
表格列表
TABLE 1 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 2 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY TYPE, 2019-2028 (UNITS)
TABLE 3 MIDDLE EAST AND AFRICA OSMOTIC LAXATIVES IN LAXATIVES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 4 MIDDLE EAST AND AFRICA OSMOTIC LAXATIVES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 5 MIDDLE EAST AND AFRICA OSMOTIC LAXATIVES WITHOUT ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 6 MIDDLE EAST AND AFRICA OSMOTIC LAXATIVES WITH ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 7 MIDDLE EAST AND AFRICA STIMULANT LAXATIVE IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 MIDDLE EAST AND AFRICA STIMULANT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 9 MIDDLE EAST AND AFRICA BULK LAXATIVES IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 MIDDLE EAST AND AFRICA BULK LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 11 MIDDLE EAST AND AFRICA LUBRICANT AND EMOLLIENT LAXATIVES IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 MIDDLE EAST AND AFRICA LUBRICANT AND EMOLLIENT LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 13 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 14 MIDDLE EAST AND AFRICA WITH FLAVOR IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 MIDDLE EAST AND AFRICA WITH FLAVOR IN LAXATIVE MARKET, BY FLAVOR, 2019-2028 (USD MILLION)
TABLE 16 MIDDLE EAST AND AFRICA WITHOUT FLAVOR IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 18 MIDDLE EAST AND AFRICA SYNTHETIC IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 MIDDLE EAST AND AFRICA SYNTHETIC IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 20 MIDDLE EAST AND AFRICA NATURAL IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 MIDDLE EAST AND AFRICA NATURAL IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 22 MIDDLE EAST AND AFRICA LAXATIVE MARKET, INDICATION, 2019-2028 (USD MILLION)
TABLE 23 MIDDLE EAST AND AFRICA CHRONIC CONSTIPATION IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 MIDDLE EAST AND AFRICA IRRITABLE BOWEL SYNDROME WITH CONSTIPATION IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 MIDDLE EAST AND AFRICA OPIOID-INDUCED CONSTIPATION IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 MIDDLE EAST AND AFRICA ACUTE CONSTIPATION IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 MIDDLE EAST AND AFRICA OTHERS IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)
TABLE 29 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (UNITS)
TABLE 30 MIDDLE EAST AND AFRICA OVER THE COUNTER IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 MIDDLE EAST AND AFRICA PRESCRIPTION IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY DOSAGE FORM, 2019-2028 (USD MILLION)
TABLE 33 MIDDLE EAST AND AFRICA TABLETS IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 MIDDLE EAST AND AFRICA CAPSULES IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 MIDDLE EAST AND AFRICA POWDER IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 36 MIDDLE EAST AND AFRICA LIQUID & GELS IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 37 MIDDLE EAST AND AFRICA SUPPOSITORIES IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 38 MIDDLE EAST AND AFRICA OTHERS IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 39 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 40 MIDDLE EAST AND AFRICA ORAL IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 41 MIDDLE EAST AND AFRICA RECTAL IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 42 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)
TABLE 43 MIDDLE EAST AND AFRICA ADULTS IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 44 MIDDLE EAST AND AFRICA CHILDREN IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 45 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 46 MIDDLE EAST AND AFRICA HOSPITALS IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 47 MIDDLE EAST AND AFRICA PHARMACY STORES IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 48 MIDDLE EAST AND AFRICA ELDERLY CARE CENTERS IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 49 MIDDLE EAST AND AFRICA HOME HEALTHCARE IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 50 MIDDLE EAST AND AFRICA GROCERY/HEALTH AND BEAUTY STORES IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 51 MIDDLE EAST AND AFRICA OTHERS IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 52 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 53 MIDDLE EAST AND AFRICA DIRECT SALES IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 54 MIDDLE EAST AND AFRICA WHOLE SALERS IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 55 MIDDLE EAST AND AFRICA OTHERS IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 56 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 57 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 58 MIDDLE EAST & AFRICA LAXATIVES MARKET, BY TYPE, 2019-2028 (UNITS)
TABLE 59 MIDDLE EAST & AFRICA STIMULANT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 60 MIDDLE EAST & AFRICA OSMOTIC LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 61 MIDDLE EAST & AFRICA OSMOTIC LAXATIVE WITH ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 62 MIDDLE EAST & AFRICA OSMOTIC LAXATIVE WITHOUT ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 63 MIDDLE EAST & AFRICA BULK LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 64 MIDDLE EAST & AFRICA LUBRICANT AND EMOLLIENT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 65 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 66 MIDDLE EAST & AFRICA WITH FLAVOR IN LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 67 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 68 MIDDLE EAST & AFRICA SYNTHETIC IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 69 MIDDLE EAST & AFRICA NATURAL IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 70 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY INDICATION, 2019-2028 (USD MILLION)
TABLE 71 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)
TABLE 72 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (UNITS)
TABLE 73 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY DOSAGE FORM, 2019-2028 (USD MILLION)
TABLE 74 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 75 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)
TABLE 76 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 77 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 78 SAUDI ARABIA LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 79 SAUDI ARABIA LAXATIVES MARKET, BY TYPE, 2019-2028 (UNITS)
TABLE 80 SAUDI ARABIA STIMULANT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 81 SAUDI ARABIA OSMOTIC LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 82 SAUDI ARABIA OSMOTIC LAXATIVE WITH ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 83 SAUDI ARABIA OSMOTIC LAXATIVE WITHOUT ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 84 SAUDI ARABIA BULK LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 85 SAUDI ARABIA LUBRICANT AND EMOLLIENT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 86 SAUDI ARABIA LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 87 SAUDI ARABIA WITH FLAVOR IN LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 88 SAUDI ARABIA LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 89 SAUDI ARABIA SYNTHETIC IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 90 SAUDI ARABIA NATURAL IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 91 SAUDI ARABIA LAXATIVE MARKET, BY INDICATION, 2019-2028 (USD MILLION)
TABLE 92 SAUDI ARABIA LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)
TABLE 93 SAUDI ARABIA LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (UNITS)
TABLE 94 SAUDI ARABIA LAXATIVE MARKET, BY DOSAGE FORM, 2019-2028 (USD MILLION)
TABLE 95 SAUDI ARABIA LAXATIVE MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 96 SAUDI ARABIA LAXATIVE MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)
TABLE 97 SAUDI ARABIA LAXATIVE MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 98 SAUDI ARABIA LAXATIVE MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 99 SOUTH AFRICA LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 100 SOUTH AFRICA LAXATIVES MARKET, BY TYPE, 2019-2028 (UNITS)
TABLE 101 SOUTH AFRICA STIMULANT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028(USD MILLION)
TABLE 102 SOUTH AFRICA OSMOTIC LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 103 SOUTH AFRICA OSMOTIC LAXATIVE WITH ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 104 SOUTH AFRICA OSMOTIC LAXATIVE WITHOUT ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 105 SOUTH AFRICA BULK LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 106 SOUTH AFRICA LUBRICANT AND EMOLLIENT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 107 SOUTH AFRICA LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 108 SOUTH AFRICA WITH FLAVOR IN LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 109 SOUTH AFRICA LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 110 SOUTH AFRICA SYNTHETIC IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 111 SOUTH AFRICA NATURAL IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 112 SOUTH AFRICA LAXATIVE MARKET, BY INDICATION, 2019-2028 (USD MILLION)
TABLE 113 SOUTH AFRICA LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)
TABLE 114 SOUTH AFRICA LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (UNITS)
TABLE 115 SOUTH AFRICA LAXATIVE MARKET, BY DOSAGE FORM, 2019-2028 (USD MILLION)
TABLE 116 SOUTH AFRICA LAXATIVE MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 117 SOUTH AFRICA LAXATIVE MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)
TABLE 118 SOUTH AFRICA LAXATIVE MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 119 SOUTH AFRICA LAXATIVE MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 120 U.A.E. LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 121 U.A.E. LAXATIVES MARKET, BY TYPE, 2019-2028 (UNITS)
TABLE 122 U.A.E. STIMULANT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028(USD MILLION)
TABLE 123 U.A.E. OSMOTIC LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 124 U.A.E. OSMOTIC LAXATIVE WITH ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 125 U.A.E. OSMOTIC LAXATIVE WITHOUT ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 126 U.A.E. BULK LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 127 U.A.E. LUBRICANT AND EMOLLIENT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 128 U.A.E. LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 129 U.A.E. WITH FLAVOR IN LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 130 U.A.E. LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 131 U.A.E. SYNTHETIC IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 132 U.A.E. NATURAL IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 133 U.A.E. LAXATIVE MARKET, BY INDICATION, 2019-2028 (USD MILLION)
TABLE 134 U.A.E. LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)
TABLE 135 U.A.E. LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (UNITS)
TABLE 136 U.A.E. LAXATIVE MARKET, BY DOSAGE FORM, 2019-2028 (USD MILLION)
TABLE 137 U.A.E. LAXATIVE MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 138 U.A.E. LAXATIVE MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)
TABLE 139 U.A.E. LAXATIVE MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 140 U.A.E. LAXATIVE MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 141 ISRAEL LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 142 ISRAEL LAXATIVES MARKET, BY TYPE, 2019-2028 (UNITS)
TABLE 143 ISRAEL STIMULANT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028(USD MILLION)
TABLE 144 ISRAEL OSMOTIC LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 145 ISRAEL OSMOTIC LAXATIVE WITH ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 146 ISRAEL OSMOTIC LAXATIVE WITHOUT ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 147 ISRAEL BULK LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 148 ISRAEL LUBRICANT AND EMOLLIENT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 149 ISRAEL LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 150 ISRAEL WITH FLAVOR IN LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 151 ISRAEL LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 152 ISRAEL SYNTHETIC IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 153 ISRAEL NATURAL IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 154 ISRAEL LAXATIVE MARKET, BY INDICATION, 2019-2028 (USD MILLION)
TABLE 155 ISRAEL LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)
TABLE 156 ISRAEL LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (UNITS)
TABLE 157 ISRAEL LAXATIVE MARKET, BY DOSAGE FORM, 2019-2028 (USD MILLION)
TABLE 158 ISRAEL LAXATIVE MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 159 ISRAEL LAXATIVE MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)
TABLE 160 ISRAEL LAXATIVE MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 161 ISRAEL LAXATIVE MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 162 KUWAIT LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 163 KUWAIT LAXATIVES MARKET, BY TYPE, 2019-2028 (UNITS)
TABLE 164 KUWAIT STIMULANT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028(USD MILLION)
TABLE 165 KUWAIT OSMOTIC LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 166 KUWAIT OSMOTIC LAXATIVE WITH ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 167 KUWAIT OSMOTIC LAXATIVE WITHOUT ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 168 KUWAIT BULK LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 169 KUWAIT LUBRICANT AND EMOLLIENT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 170 KUWAIT LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 171 KUWAIT WITH FLAVOR IN LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 172 KUWAIT LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 173 KUWAIT SYNTHETIC IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 174 KUWAIT NATURAL IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 175 KUWAIT LAXATIVE MARKET, BY INDICATION, 2019-2028 (USD MILLION)
TABLE 176 KUWAIT LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)
TABLE 177 KUWAIT LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (UNITS)
TABLE 178 KUWAIT LAXATIVE MARKET, BY DOSAGE FORM, 2019-2028 (USD MILLION)
TABLE 179 KUWAIT LAXATIVE MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 180 KUWAIT LAXATIVE MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)
TABLE 181 KUWAIT LAXATIVE MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 182 KUWAIT LAXATIVE MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 183 EGYPT LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 184 EGYPT LAXATIVES MARKET, BY TYPE, 2019-2028 (UNITS)
TABLE 185 EGYPT STIMULANT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028(USD MILLION)
TABLE 186 EGYPT OSMOTIC LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 187 EGYPT OSMOTIC LAXATIVE WITH ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 188 EGYPT OSMOTIC LAXATIVE WITHOUT ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 189 EGYPT BULK LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 190 EGYPT LUBRICANT AND EMOLLIENT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 191 EGYPT LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 192 EGYPT WITH FLAVOR IN LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 193 EGYPT LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 194 EGYPT SYNTHETIC IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 195 EGYPT NATURAL IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 196 EGYPT LAXATIVE MARKET, BY INDICATION, 2019-2028 (USD MILLION)
TABLE 197 EGYPT LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)
TABLE 198 EGYPT LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (UNITS)
TABLE 199 EGYPT LAXATIVE MARKET, BY DOSAGE FORM, 2019-2028 (USD MILLION)
TABLE 200 EGYPT LAXATIVE MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 201 EGYPT LAXATIVE MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)
TABLE 202 EGYPT LAXATIVE MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 203 EGYPT LAXATIVE MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 204 REST OF MIDDLE EAST & AFRICA LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 205 REST OF MIDDLE EAST & AFRICA LAXATIVE MARKET, BY TYPE, 2019-2028 (UNITS)
图片列表
FIGURE 1 MIDDLE EAST AND AFRICA LAXATIVE MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA LAXATIVE MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA LAXATIVE MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA LAXATIVE MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA LAXATIVE MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA LAXATIVE MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST AND AFRICA LAXATIVE MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST AND AFRICA LAXATIVE MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 MIDDLE EAST AND AFRICA LAXATIVE MARKET: MARKET INDICATION COVERAGE GRID
FIGURE 10 MIDDLE EAST AND AFRICA LAXATIVE MARKET: SEGMENTATION
FIGURE 11 RISING PREVALENCE OF CONSTIPATION, GERIATRIC POPULACE AND INCREASED USE OF OTC LAXATIVE IS EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA LAXATIVE MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 OSMOTIC LAXATIVES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA LAXATIVE MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST AND AFRICA LAXATIVE MARKET
FIGURE 14 PREVALENCE OF CONSTIPATION IN THE AMERICAS, EUROPE AND INDIA
FIGURE 15 PREVALENCE DATA INFOGRAPHICS IN ELDERLY MALES AND FEMALES REPORTED IN THE FOLLOWING COUNTRIES
FIGURE 16 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY TYPE, 2020
FIGURE 17 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY TYPE, 2019-2028 (USD MILLION)
FIGURE 18 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY TYPE, CAGR (2021-2028)
FIGURE 19 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY TYPE, LIFELINE CURVE
FIGURE 20 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY FLAVORS, 2020
FIGURE 21 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY FLAVORS, 2019-2028 (USD MILLION)
FIGURE 22 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY FLAVORS, CAGR (2021-2028)
FIGURE 23 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY FLAVORS, LIFELINE CURVE
FIGURE 24 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY SOURCE, 2020
FIGURE 25 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY SOURCE, 2019-2028 (USD MILLION)
FIGURE 26 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY SOURCE, CAGR (2021-2028)
FIGURE 27 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY SOURCE, LIFELINE CURVE
FIGURE 28 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY INDICATION, 2020
FIGURE 29 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY INDICATION, 2019-2028 (USD MILLION)
FIGURE 30 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY INDICATION, CAGR (2021-2028)
FIGURE 31 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY INDICATION, LIFELINE CURVE
FIGURE 32 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY MODE OF PURCHASE, 2020
FIGURE 33 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY MODE OF PURCHASE, 2019-2028 (USD MILLION)
FIGURE 34 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY MODE OF PURCHASE, CAGR (2021-2028)
FIGURE 35 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY MODE OF PURCHASE, LIFELINE CURVE
FIGURE 36 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY DOSAGE FORM, 2020
FIGURE 37 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY DOSAGE FORM, 2019-2028 (USD MILLION)
FIGURE 38 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY DOSAGE FORM, CAGR (2021-2028)
FIGURE 39 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY DOSAGE FORM, LIFELINE CURVE
FIGURE 40 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY ROUTE OF ADMINISTRATION, 2020
FIGURE 41 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
FIGURE 42 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2021-2028)
FIGURE 43 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 44 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY POPULATION TYPE, 2020
FIGURE 45 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY POPULATION TYPE, 2019-2028 (USD MILLION)
FIGURE 46 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY POPULATION TYPE, CAGR (2021-2028)
FIGURE 47 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY POPULATION TYPE, LIFELINE CURVE
FIGURE 48 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY SALES CHANNEL, 2020
FIGURE 49 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY SALES CHANNEL, 2019-2028 (USD MILLION)
FIGURE 50 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY SALES CHANNEL, CAGR (2021-2028)
FIGURE 51 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY SALES CHANNEL, LIFELINE CURVE
FIGURE 52 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 53 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
FIGURE 54 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 55 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 56 MIDDLE EAST & AFRICA LAXATIVE MARKET: SNAPSHOT (2020)
FIGURE 57 MIDDLE EAST & AFRICA LAXATIVE MARKET: BY COUNTRY (2020)
FIGURE 58 MIDDLE EAST & AFRICA LAXATIVE MARKET: BY COUNTRY (2021 & 2028)
FIGURE 59 MIDDLE EAST & AFRICA LAXATIVE MARKET: BY COUNTRY (2020 & 2028)
FIGURE 60 MIDDLE EAST & AFRICA LAXATIVE MARKET: BY TYPE (2021-2028)
FIGURE 61 MIDDLE EAST AND AFRICA LAXATIVE MARKET: COMPANY SHARE 2020 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
